☆ 4.6 Article

Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer

CARCINOGENESIS (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/MUC1 pathway

Qing Tang et al.

Summary: In this study, it was found that Solamargine (SM) can inhibit the growth of hepatocellular carcinoma (HCC) and enhance the anticancer effect of sorafenib (SF). SM exerts its effects through the HOTTIP-TUG1/miR-4726-5p/MUC1 signaling pathway. These findings provide potential therapeutic targets and strategies for HCC treatment.

MOLECULAR CARCINOGENESIS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Solamargine induces autophagy-mediated apoptosis and enhances bortezomib activity in multiple myeloma

Qiaoyan Han et al.

Summary: The study demonstrates that solamargine (SM) exhibits promising anti-multiple myeloma (MM) activity by suppressing MM cell viability through activating cell autophagy and inducing apoptosis. Additionally, a synergistic effect between SM and the common chemotherapeutic agent bortezomib (BTZ) is observed, suggesting a potential therapeutic strategy for treating MM.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2022)

Add to Collection

Review Oncology

Immunotherapy-based combination strategies for treatment of EGFR-TKI-resistant NSCLC

Yan Chen et al.

Summary: The rapid development of molecular targeted therapy brings hope to patients with advanced non-small-cell lung cancer. However, drug resistance occurs during EGFR-TKI treatment. Osimertinib shows a favorable prognosis, but acquired resistance is still a challenge. PD-1 and PD-L1 inhibitors have made progress, especially in patients with no actionable mutations. This review summarizes the relationship between EGFR mutations and PD-L1 expression and important clinical studies on immunotherapy-inhibitor-based treatment in EGFR-TKI-resistant NSCLC patients.

FUTURE ONCOLOGY (2022)

Add to Collection

Letter Oncology

Solamargine induces hepatocellular carcinoma cell apoptosis and autophagy via inhibiting LIF/miR-192-5p/CYR61/Akt signaling pathways and eliciting immunostimulatory tumor microenvironment

Shuangshuang Yin et al.

Summary: This study demonstrates that solamargine (SM) inhibits the proliferation of hepatocellular carcinoma (HCC) and induces HCC cell apoptosis and autophagy in vitro and in vivo. It exerts its anti-tumor effects through the LIF/miR-192-5p/CYR61/Akt signaling pathways and also affects tumor-associated macrophages and other immune cell populations in the HCC microenvironment.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Add to Collection

Article Oncology

Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling

Jianchao Ge et al.

Summary: Prostate cancer is a major cause of cancer in men worldwide, and the treatment for castration-resistant prostate cancer remains challenging. This study found that a natural alkaloid called solamargine can inhibit the growth of castration-resistant prostate cancer by suppressing the PI3K/Akt signaling pathway, and solamargine can enhance the effectiveness of docetaxel.

JOURNAL OF ONCOLOGY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Eleanor L. Watts et al.

Summary: This study found that circulating IGF-I is positively associated with the risk of prostate cancer, particularly aggressive prostate cancer. Higher levels of IGF-II and IGFBP-3 are also associated with increased risk of overall prostate cancer, while higher levels of IGFBP-1 are associated with a decreased risk, but these associations are attenuated after adjusting for IGF-I.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Non-coding RNAs and potential therapeutic targeting in cancer

Shusuke Toden et al.

Summary: Recent advances have highlighted the importance of non-coding RNAs, particularly microRNAs, in cancer pathogenesis. These ncRNAs have shown potential for therapeutic development in cancer, with early data from pre-clinical studies demonstrating promising results in human trials. While miRNAs have been extensively studied, there is ongoing research to uncover the molecular mechanisms and therapeutic targets of other lesser studied ncRNAs in cancer treatment.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p

Dong-Liang Chen et al.

Summary: The study highlights the upregulation of circDLG1 in distant metastatic lesions and gastric cancer tissues resistant to anti-PD-1 therapy, correlating with aggressive tumor phenotype and poor prognosis. Ectopic circDLG1 expression promotes proliferation, migration, invasion, and immune evasion of gastric cancer cells. Mechanistically, circDLG1 interacts with miR-141-3p as a miRNA sponge to increase CXCL12 expression, promoting gastric cancer progression and resistance to anti-PD-1 therapy.

MOLECULAR CANCER (2021)

Add to Collection

Article Multidisciplinary Sciences

A novel biosensor for the ultrasensitive detection of the lncRNA biomarker MALAT1 in non-small cell lung cancer

Mei Chen et al.

Summary: A novel electrochemical biosensor based on a gold nanocage and multi-walled carbon nanotube-modified screen-printed carbon electrode for detecting lncRNAs showed a wide linear range and low detection limit, with good selectivity and stability, as well as lower cost and faster detection speed compared to traditional methods.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer

Bela Goyal et al.

Summary: MALAT1 is a widely studied lncRNA in cancer, playing an important role in tumorigenesis and development, localized in the periphery of nuclear speckles. Molecular tools have shown its diagnostic, prognostic, and therapeutic potential in various cancers.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection

Review Oncology

Novel Insights Into MALAT1 Function as a MicroRNA Sponge in NSCLC

Qinfeng Zhou et al.

Summary: The long non-coding RNA MALAT1 is overexpressed in NSCLC and is associated with tumor size, stage, metastasis, and invasion, making it a potential biomarker for early diagnosis and prognosis evaluation of the disease.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2

S. J. Tong et al.

Summary: miR-141-3p inhibits colon cancer cells proliferation and migration by regulating the Bcl2 gene, making it a potential therapeutic target for colon cancer.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Add to Collection

Article Oncology

MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer

Chuansheng Yang et al.

Summary: This study revealed that MALAT1 is up-regulated in HER2-positive breast cancer and silencing MALAT1 could inhibit cell proliferation. Knockdown of MALAT1 affects the expression of specific genes, indicating MALAT1 might be a potential therapeutic target for HER2-positive breast cancer.

CURRENT CANCER DRUG TARGETS (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Original LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p/RBMS3 axis

Shiliang Dong et al.

Summary: MEG3 and RBMS3 are low-expressed in breast cancer, negatively correlated with miR-141-3p, and positively correlated with each other. MEG3 inhibits BC cell proliferation and promotes apoptosis by down-regulating miR-141-3p and up-regulating RBMS3.

GENOMICS (2021)

Add to Collection

Article Gastroenterology & Hepatology

LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC

Luyuan Ma et al.

Summary: LINC01134 was found to be up-regulated in OXA-resistant cells and predicted poor therapeutic efficacy of OXA. It activates the anti-oxidative pathway through p62 by recruiting transcription factor SP1 to the p62 promoter, thereby regulating cell viability, apoptosis, and mitochondrial homeostasis. In HCC patients, LINC01134 expression was positively correlated with p62 and LSD1 expressions, while SP1 expression was positively correlated with p62 expression.

HEPATOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A

Di Wang et al.

Summary: This study found that overexpression of miR-146b-3p in CRC is associated with poor overall survival, and it can promote the proliferation, migration, and invasion of CRC cells while suppressing apoptosis. Furthermore, SP1 overexpression significantly increases miR146b-3p expression, decreases FAM107A expression, and promotes the G1/S transition.

LIFE SCIENCES (2021)

Add to Collection

Article Oncology

IncRNA MALAT1/miR-26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines

Nan Wang et al.

Summary: MALAT1 plays crucial roles in the development and progression of breast cancer by modulating ST8SIA4 levels, while miR-26a/26b is identified as a direct regulator of MALAT1 and associated with ST8SIA4. The MALAT1/miR-26a/26b/ST8SIA4 axis may serve as a potential therapeutic target for breast cancer progression.

ONCOLOGY REPORTS (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

MicroRNA-199-3p targets Sp1 transcription factor to regulate proliferation and epithelial to mesenchymal transition of human lung cancer cells

Jiajia Fu et al.

Summary: The study demonstrates that miRNA-199-3p regulates the growth and metastasis of SK-LU-1 lung cancer cells by suppressing Sp1, showing potential inhibitory effects on lung cancer.

3 BIOTECH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA

Melissa F. Adasme et al.

Summary: With the growth of protein structure data, the analysis of molecular interactions between ligands and their target molecules becomes increasingly important. PLIP, a tool for protein-ligand interaction profiling, has been successful in detecting and visualizing these interactions, with applications ranging from characterizing docking experiments to evaluating novel ligand-protein complexes. Additionally, PLIP has been extended to encompass interactions with DNA and RNA, demonstrating its utility in scenarios such as cancer drug targeting DNA and RNA-protein complexes associated with neurological diseases.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Article Oncology

MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma

Tianbo Xu et al.

Summary: This study discovered that monocytes and TNM stage are independent prognostic factors in ccRCC, and identified nine hub genes that differ between high and low-risk clusters. MMP9 and IGFBP1 play crucial roles in regulating tumor immunity, making them potential biomarkers and therapeutic targets for ccRCC immunotherapy.

JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

LINC01296/miR-141-3p/ZEB1-ZEB2 axis promotes tumor metastasis via enhancing epithelial-mesenchymal transition process

Zhenqiang Sun et al.

Summary: This study found that LINC01296 is highly expressed in NSCLC and CRC tissues, and is associated with poor prognosis. LINC01296 regulates invasion and metastasis of NSCLC and CRC by modulating the EMT process.

JOURNAL OF CANCER (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Regulatory Mechanism of MicroRNA Expression in Cancer

Zainab Ali Syeda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Chemistry, Medicinal

The regulation and interaction of colon cancer-associated transcript-1 and miR7-5p contribute to the inhibition of SP1 expression by solamargine in human nasopharyngeal carcinoma cells

JingJing Wu et al.

PHYTOTHERAPY RESEARCH (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer

Yang-Hsiang Lin

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Hypoxia-responsive miR-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1 alpha signaling pathway

Shanping Sun et al.

JOURNAL OF GENE MEDICINE (2020)

Add to Collection

Article Chemistry, Medicinal

Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells

Qing Tang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Add to Collection

Article Oncology

LncRNA MALAT I Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway

Qingqiang Dai et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Add to Collection

Article Endocrinology & Metabolism

IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation

Yan Zheng et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells

Nan Zhang et al.

MOLECULAR CANCER (2020)

Add to Collection

Review Oncology

Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review

Yijia Guo et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

miRNA-based biomarkers, therapies, and resistance in Cancer

Boxue He et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Add to Collection

Article Oncology

IGFBP1 Is a Predictive Factor for Haematogenous Metastasis in Patients With Gastric Cancer

Yuya Sato et al.

ANTICANCER RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

MiR-141-3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer

Zhi Liang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Add to Collection

Review Medicine, General & Internal

Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review

Kathryn C. Arbour et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Article Cell Biology

Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer

Qing Tang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Add to Collection

Article Pharmacology & Pharmacy

Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells

Tomoya Takenaka et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

被撤回的出版物: YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer (Retracted article. See JUL, 2023)

Zhenqiang Sun et al.

ONCOGENE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer

Zhenqiang Sun et al.

ONCOGENE (2019)

Add to Collection

Article Pathology

Insulin-like growth factor binding protein-1 (IGFBP-1) upregulated by Helicobacter pylori and is associated with gastric cancer cells migration

Caifeng Luo et al.

PATHOLOGY RESEARCH AND PRACTICE (2017)

Add to Collection

Article Cell Biology

Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1

Qing Tang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Add to Collection

Article Cell Biology

Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer (Withdrawn Publication)

Qing Tang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Add to Collection

Article Oncology

Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells

Li Jun Yang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)

Add to Collection

Article Cell Biology

Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer

Mohamad Nasir Shafiee et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)

Add to Collection

Article Cell Biology

Inhibition of integrin-linked kinase expression by emodin through crosstalk of AMPKα and ERK1/2 signaling and reciprocal interplay of Sp1 and c-Jun

Qing Tang et al.

CELLULAR SIGNALLING (2015)

Add to Collection

Article Toxicology

Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity

Iman Karimi Sani et al.

TOXICOLOGY IN VITRO (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.